BNGO experienced a profit of 5.80% in the preceding month, courtesy of an AI-powered trading robot.
This AI trading robot, accessible at Swing Trader: High Volatility Stocks for Active Trading (TA&FA), was one of the best in our robot factory, generating a 5.80% gain for BNGO over the course of the previous month.
One of the indicators that this robot uses is the Moving Average Convergence Divergence (MACD). For BNGO, the MACD turned positive on March 27, 2023. This is a bullish signal that indicates the stock is likely to continue rising. In fact, looking at past instances where BNGO's MACD turned positive, the stock continued to rise in 36 of 40 cases over the following month. This puts the odds of a continued upward trend at an impressive 90%.
With the help of AI trading robots like the one at Swing Trader: High Volatility Stocks for Active Trading (TA&FA), investors can benefit from the power of data analysis and automation to make better trading decisions. By using technical indicators like the MACD, these robots can help investors identify potential opportunities and manage risk more effectively. It is important, however, to remember that no trading strategy or robot is infallible, and investors should always conduct their own research and analysis before making any trading decisions.
Momentum Indicator for BNGO turns negative, indicating new downward trend
BNGO saw its Momentum Indicator move below the 0 level on July 14, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 86 similar instances where the indicator turned negative. In of the 86 cases, the stock moved further down in the following days. The odds of a decline are at .
Technical Analysis (Indicators)
Bearish Trend Analysis
BNGO moved below its 50-day moving average on July 13, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for BNGO crossed bearishly below the 50-day moving average on June 11, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BNGO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
BNGO broke above its upper Bollinger Band on July 10, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for BNGO entered a downward trend on July 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 68 cases where BNGO's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for BNGO just turned positive on July 01, 2026. Looking at past instances where BNGO's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BNGO advanced for three days, in of 218 cases, the price rose further within the following month. The odds of a continued upward trend are .
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.352) is normal, around the industry mean (4.541). P/E Ratio (0.002) is within average values for comparable stocks, (189.776). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.492). Dividend Yield (0.000) settles around the average of (0.023) among similar stocks. P/S Ratio (0.301) is also within normal values, averaging (83.137).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BNGO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BNGO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a developer of technologies for analysis of large biological molecules
Industry PharmaceuticalsOther
Advertisement